Seroprevalence of antibodies for pertussis and diphtheria among people leaving or entering China: a cross-sectional study. 2019

Hui Han, and Zhiqiang Fang, and Xiangguang Ye, and Hailei Wu, and Feng Zuo, and Quan Shi, and Jinping Mu, and Baoliang Xu
Chinese Academy of Inspection and Quarantine, Beijing, China. hanhui2002@163.com.

Despite high population immunity, pertussis remains one of the leading causes of vaccine-preventable deaths worldwide. The aim of this study was to determine the seroprevalence of IgG antibodies to pertussis toxin (PT) and diphtheria among the adult male population leaving or entering China. Blood samples were obtained from 240 Chinese and 207 African healthy adults that were leaving and entering China, respectively. Serum IgG antibodies against PT (anti-PT IgG) and diphtheria were determined. The mean concentration of anti-PT IgG antibodies was 13.82 IU/mL and 18.11 IU/mL for the leaving and entering populations, respectively. None of the studied Chinese leaving China were seropositive for pertussis. Of the 240 subjects leaving China, 209 (87.1%) had anti-diphtheria antibody concentrations of ≥ 0.1 IU/mL and 31 (12.9%) had antibody concentrations between 0.01 and 0.099 IU/mL. Eleven (5.31%) of the studied Africans entering China had anti-PT IgG antibodies higher than 30 IU/mL and thus were considered seropositive for pertussis. Of the 207 Africans entering China, antibody concentrations of ≥ 0.1 IU/mL were found in 164 subjects (79.2%) while 43 (20.8%) had antibody concentrations between 0.01 and 0.099 IU/mL. Almost all Chinese adult men leaving China and most African men entering China have very low serum antibody levels of pertussis. Furthermore, the antibody level of diphtheria among these two populations was low among adults. A larger population study is needed to determine whether booster vaccinations against pertussis and diphtheria should be considered for adults in China and also for Africans entering China.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004165 Diphtheria A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects. Corynebacterium diphtheriae Infection,Corynebacterium diphtheriae Infections,Infection, Corynebacterium diphtheriae
D004651 Employment The state of being engaged in an activity or service for wages or salary. Employment Termination,Employment Status,Labor Force,Occupational Status,Status, Occupational,Underemployment,Labor Forces,Status, Employment,Termination, Employment
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000076082 Travel-Related Illness Health problems associated with TRAVEL. Travel Sickness,Travel-Associated Infections,Travel-Associated Infectious Diseases,Travel-Related Disease,Travel-Related Health Problems,Travel-Related Infections,Travel-Related Infectious Diseases,Travel-Related Sickness,Disease, Travel-Associated Infectious,Disease, Travel-Related,Disease, Travel-Related Infectious,Diseases, Travel-Associated Infectious,Diseases, Travel-Related,Diseases, Travel-Related Infectious,Health Problem, Travel-Related,Health Problems, Travel-Related,Illness, Travel-Related,Illnesses, Travel-Related,Infection, Travel-Associated,Infection, Travel-Related,Infections, Travel-Associated,Infections, Travel-Related,Infectious Disease, Travel-Associated,Infectious Disease, Travel-Related,Infectious Diseases, Travel-Associated,Infectious Diseases, Travel-Related,Problem, Travel-Related Health,Problems, Travel-Related Health,Sickness, Travel,Sickness, Travel-Related,Sicknesses, Travel,Sicknesses, Travel-Related,Travel Associated Infections,Travel Associated Infectious Diseases,Travel Related Disease,Travel Related Health Problems,Travel Related Illness,Travel Related Infections,Travel Related Infectious Diseases,Travel Related Sickness,Travel Sicknesses,Travel-Associated Infection,Travel-Associated Infectious Disease,Travel-Related Diseases,Travel-Related Health Problem,Travel-Related Illnesses,Travel-Related Infection,Travel-Related Infectious Disease,Travel-Related Sicknesses
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Hui Han, and Zhiqiang Fang, and Xiangguang Ye, and Hailei Wu, and Feng Zuo, and Quan Shi, and Jinping Mu, and Baoliang Xu
December 2011, The Journal of infection,
Hui Han, and Zhiqiang Fang, and Xiangguang Ye, and Hailei Wu, and Feng Zuo, and Quan Shi, and Jinping Mu, and Baoliang Xu
January 2015, Human vaccines & immunotherapeutics,
Hui Han, and Zhiqiang Fang, and Xiangguang Ye, and Hailei Wu, and Feng Zuo, and Quan Shi, and Jinping Mu, and Baoliang Xu
January 2019, Vaccine,
Hui Han, and Zhiqiang Fang, and Xiangguang Ye, and Hailei Wu, and Feng Zuo, and Quan Shi, and Jinping Mu, and Baoliang Xu
July 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Hui Han, and Zhiqiang Fang, and Xiangguang Ye, and Hailei Wu, and Feng Zuo, and Quan Shi, and Jinping Mu, and Baoliang Xu
November 2022, Human vaccines & immunotherapeutics,
Hui Han, and Zhiqiang Fang, and Xiangguang Ye, and Hailei Wu, and Feng Zuo, and Quan Shi, and Jinping Mu, and Baoliang Xu
December 2018, BMC pediatrics,
Hui Han, and Zhiqiang Fang, and Xiangguang Ye, and Hailei Wu, and Feng Zuo, and Quan Shi, and Jinping Mu, and Baoliang Xu
January 2013, Roumanian archives of microbiology and immunology,
Hui Han, and Zhiqiang Fang, and Xiangguang Ye, and Hailei Wu, and Feng Zuo, and Quan Shi, and Jinping Mu, and Baoliang Xu
May 2009, BMC infectious diseases,
Hui Han, and Zhiqiang Fang, and Xiangguang Ye, and Hailei Wu, and Feng Zuo, and Quan Shi, and Jinping Mu, and Baoliang Xu
May 2020, Vaccine,
Hui Han, and Zhiqiang Fang, and Xiangguang Ye, and Hailei Wu, and Feng Zuo, and Quan Shi, and Jinping Mu, and Baoliang Xu
April 2018, Orvosi hetilap,
Copied contents to your clipboard!